Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Extracorporeal Photopheresis for the Prevention of Early Cardiac Allograft Vasculopathy Detected by Optical Coherence Tomography

NCT04226521 is registered in ClinicalTrials.gov with Bosko Skoric as lead sponsor.

NCT NCT04226521
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04226521 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Extracorporeal Photopheresis for the Prevention of Early Cardiac Allograft Vasculopathy Detected by Optical Coherence Tomography
Lead sponsor
Bosko Skoric
Phase
Not applicable
Overall status
Completed
Start date
January 1, 2018
Completion date
October 17, 2023
Enrollment
38 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac allograft vasculopathy, heart transplant rejection